PHI on the alliance for cell-based biomanufacturing

Phase Holographic Imaging, PHI, recently created a US-based alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, QIAGEN and global...
Abliva patientfokus i fas II/III studie

Patient perspective in focus in Abliva’s phase II/III study

Biotech company Abliva is now preparing for the perhaps biggest step in the company's history to date – a pivotal phase II/III study with...
DanCann Pharmas CEO Jeppe Krog Rasmussen in the BioStock studio

DanCann Pharma about the road to commercial breakthrough

DanCann Pharma is active within a growing field of drug development – medical cannabis and therapeutic cannabinoids. The goal is to provide patients in...
Thomas Jonassen

SynAct Pharma’s CSO comments approved IND and Q3

SynAct Pharma has received IND approval from the FDA, meaning that they can initiate the phase IIa/b RESOLVE study of AP1189 in DMARD-IR patients....

DanCann Pharma rides the cannabis legalisation wave

We are seeing a shift in the political will to decriminalise cannabis, not least in the US and Germany, where significant steps in legislature...
DanCann Pharmas vd Jeppe Krog Rasmussen presenterar i BioStocks studio

BioStock Investor Pitch: DanCann Pharma

Danish DanCann Pharma's goal is to improve the lives of patients through medical cannabis and cannabinoids. The company has signed an agreement with WEECO...
Meeting room with people

ClearPoint Neuro delivers first order to CLS

Following the FDA clearance of Clinical Laserthermia Systems’ MR-guided laser ablation system in neurosurgery, US commercialisation was swiftly initiated. The commercialisation is led by...
Eir Ventures Sound Bioventures NLSDays2022

NLSDays: Sound Bioventures and Eir Ventures on the investment climate

One of NLSDays’ main aims is to connect investors and life science companies. Thus, several venture capital funds were present during the event in...
CLS vd Dan Mogren besöker BioStocks studio

BioStock Studio: CLS about the FDA clearance

In December last year, medtech Clinical Laserthermia Systems applied for FDA clearance for the second generation of the TRANBERG Thermal Therapy System with Thermoguide...
Anders Svensson, CFO på OssDsign

BioStock Investor Meeting: Interview with OssDsign

In connection with the BioStock Investor Meeting in Stockholm, BioStock's reporter was visited by Anders Svensson, CFO of OssDsign. Svensson told us more about...